Apoptosis in androgen-independent mouse mammary tumor cells induced by 5-fluorodeoxyuridine but not by androgen withdrawal

Anticancer Research

Volumn 16, Issue 5 A, 1996, Pages 2613-2618

  Furuya, Yuzo ^a   Shimazaki, Jun ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

5 fluorodeoxyuridine; Androgen; Apoptosis; Chiba subline 2; Shionogi carcinoma 115

Indexed keywords

ACTIN; ANDROGEN; CALMODULIN; FLOXURIDINE; GLUCOSE REGULATED PROTEIN; MESSENGER RNA; PROTHYMOSIN ALPHA; TESTOSTERONE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST TUMOR; CONTROLLED STUDY; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CELL DIVISION; CLUSTERIN; CULTURE MEDIA, SERUM-FREE; DNA FRAGMENTATION; DNA, NEOPLASM; FLOXURIDINE; GLYCOPROTEINS; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MICE; MOLECULAR CHAPERONES; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; PROGESTERONE; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0029961338     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Isaacs JT: Antagonistic effect of androgen on prostatic cell death. Prostate 5: 545-557, 1984.
2. Kerr JFR and Searle J: Deletion of cells by apoptosis during castration-induced involution of the rat prostate. Virchows. Arch. (Cell Pathol.) 13: 87-102, 1973.
3. Kyprianou N and Isaacs JT: Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 122: 552-562, 1988.
4. Lee C and Sensihar JA: Protein of the rat prostate, synthesis of new proteins in the ventral lobe during castration induced regression. J Urol. 38: 903-908, 1985.
5. Montpetit ML, Lawless KR and Tenniswood M: Androgen repressed messages in the rat ventral prostate. Prostate 8: 25-36, 1986.
6. Kyprianou N, English H and Isaacs JT: Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res 50: 3748-3753, 1990.
7. Sinha AA, Blackhard CE and Seal US: A critical analysis of tumor morphology and hormone treatment in the untreated and estrogen treated responsive and refractory human prostatic carcinoma. Cancer 40: 2836-2850, 1977.
8. Schulze H, Isaacs JT and Senge T: Inability of complete androgen blockade to increase survival of patients with advanced prostate cancer as compared to standard hormonal therapy. J Urol 137: 909-911, 1987.
9. Ichikawa T, Akimoto S, Hayata I and Shimazaki J: Progression and selection in heterogeneous tumor composed of androgen-responsive Shionogi Carcinoma 115 and its autonomous subline (Chiba Subline 2). Cancer Res 49: 367-371, 1989.
10. Furuya Y, Sato N, Akakura K, Ichikawa T, Suzuki N, Sato R and Shimazaki J: Paracrine growth stimulation of androgen-responsive Shionogi Carcinoma 115 by its autonomous subline (Chiba Suhline). Cancer Res 50: 4979-4983, 1990.
11. Furuya Y, Isaacs JT and Shimazaki J: Induction of programmed death/ apoptosis in androgen dependent mouse mammary tumor cell line (Shionogi carcinoma 115) by androgen withdrawal. Jpn J Cancer Res 86: 1159- 1165, 1995.
12. Sato N, Watabe Y, Suzuki H and Shimazaki J: Progression of androgen-sensitive mouse tumor (Shionogi Carcinoma 115) to androgen-insensitive tumor after long-term removal of testosterone. Jpn J Cancer Res 84: 1300-1308, 1993.
13. Furuya Y, Sato N, Watabe Y and Shimazaki J: Appearance of malignant phenotype with partial loss of hormone dependency in androgen-dependent Shionogi Carcinoma 115 transfected with hst-1 gene. Jpn J Cancer Res 82: 1245-1251, 1991.
14. Ueda N and Shah SV: Endonuclease-induced DNA damage and cell death in oxidant injury to renal tubular epithelial cells. J Clin Invest 90: 2593-2597, 1992.
15. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
16. Furuya Y and Isaacs JT: Differential gene regulation during programmed death (apoptosis) versus proliferation of prostatic glandular cells induced by androgen manipulation. Endocrinology 133: 2660-2666, 1994.
17. Kyprianou N and Isaacs JT: Expression of transforming growth factor-ß in the rat ventral prostate during castration-induced programmed cell death. Mol Endocrinol 3: 1515- 1522, 1989.
18. Buttyan R, Olsson CA, Pintar J, Chang C, Bandyk M, Ng P and Sawczuk IS: Induction of the TRPM-2 gene in cells undergoing programmed death. Mol Cell Biol 9: 3473-3481, 1989.
19. 2+-dependent endonuclease as an early event in castration-induced prostatic cell death. Prostate 13: 103 - 117, 1988.
20. Berges R, Furuya Y, Remington L, English HF, Jacks T and Isaacs JT: Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation. Proc Natl Acad Sci USA 90: 8910-8914, 1994.
21. Furuya Y, Lin XS, Walsh JC, Nelson WG and Isaacs JT: Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction. Endocrinology 136: 1898-1906, 1995.
22. Kyprianou N and Isaacs JT: "Thymineless" death in androgen-independent prostatic cancer cells. Biochem Biophys Res Commun 165: 73-81, 1989.
23. Armstrong DK, Isaacs JT, Ottaviano YL and Davidson NE: Programmed cell death in an estrogen-independent human breast cancer cell line, MDA-MB-468. Cancer Res 52: 34183424, 1992.
24. Kyprianou N, Bains AK and Jacobs SC: Inducbon of apoptosis in androgen-independent human prostate cancer cells undergoing thymineless death. Prostate 25: 66-75, 1994.
25. Sylvester SR, Shnner MK and Gnswold MD: A sulfated glycoprotein synthesized by Sertoli cells and by epididymal cells is a component of the sperm membrane. Biol Reprod 31: 1087-1101, 1984.
26. Thomas P and Meizel S: An influx of extracellular calcium is required for initiation of the human sperm acrosomal reaction induced by human follicular fluid. Gamete Res 20: 397-411, 1988.
27. Kyprianou N and Isaacs JT: Identification of a cellular receptor for transforming growth factor-ß in rat ventral prostate and its negative regulation by androgens. Endocrinology 123: 2124-2131, 1988.
28. Martikainen P, Kyprianou N and Isaacs JT: Effect of transforming growth factor-ß1 on proliferation and death of rat prostatic cells. Endocrinology 127: 2963-2968, 1990.
29. Furuya Y, Lundmo P, Short AD, Gill DL and Isaacs JT: The role of calcium, pH. and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin. Cancer Res 54: 6167-6175, 1994.